Boston Scientific warns of tough 2027 on China pricing, heart-device weakness

By Padmanabhan Ananthan Oct 28 (Reuters) – Boston Scientific lowered its full-year profit forecast on Wednesday and warned that revenue and earnings growth could be challenging in 2027, citing pricing pressure in China and weakness in its key heart-device businesses. Shares of the company were down 5.3% by afternoon. “We anticipate continued top-line pressure into 2027, which we expect will make…

Open True Mainstream to compare left, right, and center coverage

1,600+ newsrooms tracked, in English, around the clock. Real newsrooms only — no NGOs, no press releases. Left/Right tags come from reader feedback. No algorithmic feed.